IR-Med, Inc.

IR-Med, Inc. is a U.S.-based medical technology company in the electromedical and electrotherapeutic apparatus field. Based on its filings, the company appears to be developing and commercializing medical devices and related technologies, with operations exposed to manufacturing, sourcing, and regulatory execution risks.

0.38

0.38

— IR-Med, Inc.
%
Electromedical devices70% Medical devices that use electrical or electromagnetic technology for diagnosis or therapy.
Device development20% Engineering, prototyping, and product development activities for new medical technologies.
Manufacturing and sourcing10% Procurement of raw materials, components, and production support for device output.

IR-Med’s customers are likely healthcare providers, distributors, and other medical-device channel partners that buy...

  • Healthcare providersprimary

    Hospitals, clinics, and medical practices that buy devices for clinical diagnosis or therapy.

  • Distributors and channel partnerssecondary

    Medical-device distributors that purchase inventory for resale into healthcare markets.

  • International customerssecondary

    Overseas buyers and partners whose demand is affected by trade policy, tariffs, and logistics.

IR-Med is headquartered in the United States, and its filings highlight exposure to U.S...

  • •United States is the core operating and reporting base
  • •Trade policy changes can affect imported components and costs
  • •Supply chain may span foreign manufacturing and sourcing locations
  • •Customer markets may include countries affected by tariffs
  • •International logistics can influence production timing and margins

The company’s near-term focus appears centered on advancing product development while maintaining supply continuity and...

01
Supply-chain resilienceshort-term

Tariffs and trade tensions can raise costs or interrupt component availability.

02
Product commercializationmedium-term

A medical-device company needs successful development and market adoption to scale.

IR-Med faces material exposure to tariff changes, trade restrictions, and supply-chain disruption because its products...

high

Tariff-driven input cost inflation

U.S. tariffs may increase the cost of raw materials and components used in products.

Scope
Manufacturing costs and gross margin
Materiality
high
high

Supply-chain disruption

Escalating trade tensions can delay sourcing, production, and delivery timelines.

Scope
Operations and customer fulfillment
Materiality
high
medium

Commercialization and adoption risk

Medical-device products can face slow market acceptance and long sales cycles.

Scope
Revenue growth and operating leverage
Materiality
medium
medium

Regulatory and compliance risk

Electromedical products typically require approvals and ongoing compliance oversight.

Scope
Product launch timing and market access
Materiality
medium
Inventory and input-cost accounting
Gross margin and working capital
Revenue recognition timing
Quarterly revenue comparability
Development cost treatment
Operating loss and asset balances
Impairment and reserve estimates
Earnings volatility

IRADIMED CORP

IRMD · Surgical & Medical Instruments & Apparatus

Streamex Corp.

STEX · Electromedical & Electrotherapeutic Apparatus

ENvue Medical, Inc.

FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies

MIRA PHARMACEUTICALS, INC.

MIRA · Pharmaceutical Preparations

ORAMED PHARMACEUTICALS INC.

ORMP · Pharmaceutical Preparations

MERIT MEDICAL SYSTEMS INC

MMSI · Surgical & Medical Instruments & Apparatus

: 28/04/2026